Mutation of Asn293 to Asp in Transmembrane Helix VI Abolishes Agonist-Induced but Not Constitutive Activity of the β2-Adrenergic Receptor
- 1 December 2002
- journal article
- Published by Elsevier in Molecular Pharmacology
- Vol. 62 (6) , 1431-1437
- https://doi.org/10.1124/mol.62.6.1431
Abstract
The peptide transporter PEPT2, expressed in a variety of tissues, including kidney, lung, and the central nervous system, mediates the uphill transport of di- and tripeptides, as well as a variety of peptidomimetic drugs. To identify the essential molecular features of substrates that determine affinity and transport by PEPT2, we synthesized a series of amino acid derivatives as well as modified dipeptides. Kinetic constants for the interaction of test compounds with PEPT2 were obtained in a competition assay using Pichia pastoris yeast cells expressing mammalian PEPT2. The two-electrode voltage-clamp technique in Xenopus laevisoocytes was used to assess the substrate's electrogenic transport properties. Whereas ϖ-amino fatty acids showed no affinity for PEPT2, the introduction of a single carbonyl group into the backbone increased both affinity and transport currents more than 30-fold. ϖ-Amino fatty acids, at their amino or carboxyl group coupled to an alanine residue, allowed us to determine the importance of the spatial position of functional groups within the molecule. Affinity and transport function declined by elongating the ϖ-amino acid chain when located in the N-terminal position, whereas the elongation in the carboxyl terminal with an N-terminal alanine caused less pronounced effects. The results clearly establish that a free N terminus, a correctly positioned backbone carbonyl group, and a carboxylic group that is in a suitable distance from the intramolecular carbonyl function and the amino terminal head group are the main features for substrate recognition and transport by PEPT2. This information provides the framework for a rational design of peptidomimetic drugs for delivery via PEPT2.Keywords
This publication has 39 references indexed in Scilit:
- Mutational and Computational Analysis of the α1b-Adrenergic ReceptorJournal of Biological Chemistry, 2001
- Structural Mimicry in G Protein-Coupled Receptors: Implications of the High-Resolution Structure of Rhodopsin for Structure-Function Analysis of Rhodopsin-Like ReceptorsMolecular Pharmacology, 2001
- Agonists induce conformational changes in transmembrane domains III and VI of the beta 2 adrenoceptorThe EMBO Journal, 1997
- Requirement of Rigid-Body Motion of Transmembrane Helices for Light Activation of RhodopsinScience, 1996
- Physiological effects of inverse agonists in transgenic mice with myocardial overexpression of the β2-adrenoceptorNature, 1995
- Adrenergic Receptors as Models for G Protein-Coupled ReceptorsAnnual Review of Neuroscience, 1992
- Antagonists with negative intrinsic activity at delta opioid receptors coupled to GTP-binding proteins.Proceedings of the National Academy of Sciences, 1989
- cDNA for the human beta 2-adrenergic receptor: a protein with multiple membrane-spanning domains and encoded by a gene whose chromosomal location is shared with that of the receptor for platelet-derived growth factor.Proceedings of the National Academy of Sciences, 1987
- Beta-adrenergic receptor kinase: identification of a novel protein kinase that phosphorylates the agonist-occupied form of the receptor.Proceedings of the National Academy of Sciences, 1986
- An operational model of pharmacological agonism: the effect of E/[A] curve shape on agonist dissociation constant estimationBritish Journal of Pharmacology, 1985